Neutralizing and non-neutralizing monoclonal antibodies against dengue virus e protein derived from a naturally infected patient

Virology Journal

Volumn 7, Issue , 2010, Pages

  Schieffelin, John S ^a   Costin, Joshua M ^b   Nicholson, Cindo O ^b   Orgeron, Nicole M ^a   Fontaine, Krystal A ^b,c   Isern, Sharon ^b   Michael, Scott F ^b   Robinson, James E ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FLORIDA GULF COAST UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VIRUS E PROTEIN; DENGUE VIRUS E PROTEIN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CONTROLLED STUDY; DENGUE; DRUG PROTEIN BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTERFEROMETRY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; ANTIBODY DEPENDENT ENHANCEMENT; CELL CULTURE; CELL LINE; DENGUE VIRUS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; ISOLATION AND PURIFICATION; MACROPHAGE; PROTEIN BINDING; UNITED STATES; VIROLOGY; VIRUS CELL TRANSFORMATION;

DENGUE VIRUS; HUMAN HERPESVIRUS 4;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT ENHANCEMENT; B-LYMPHOCYTES; CELL LINE; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; DENGUE VIRUS; EPITHELIAL CELLS; HERPESVIRUS 4, HUMAN; HUMANS; MACROPHAGES; PROTEIN BINDING; UNITED STATES; VIRAL ENVELOPE PROTEINS;

EID: 77749304414     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-28     Document Type: Article

References (34)

1. Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication. K Laoprasopwattana DH Libraty TP Endy A Nisalak S Chunsuttiwat FA Ennis, et al. J Infect Dis 2007 195 8 1108 16
2. Research on dengue during World War II. AB Sabin, Am J Trop Med Hyg 1952 1 1 30 50
3. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. N Sangkawibha S Rojanasuphot S Ahandrik S Viriyapongse S Jatanasen V Salitul, et al. Am J Epidemiol 1984 120 5 653 69
4. Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. SB Halstead, Yale J Biol Med 1970 42 5 350 62
5. The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. KJ Huang YC Yang YS Lin JH Huang HS Liu TM Yeh, et al. J Immunol 2006 176 5 2825 32
6. Dengue vaccines: problems and prospects. UC Chaturvedi R Shrivastava R Nagar, Indian J Med Res 2005 121 5 639 52
7. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. FA Rey FX Heinz C Mandl C Kunz SC Harrison, Nature 1995 375 6529 291 8
8. A ligand-binding pocket in the dengue virus envelope glycoprotein. Y Modis S Ogata D Clements SC Harrison, Proc Natl Acad Sci USA 2003 100 12 6986 91 PMCID: 165817
9. Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. T Oliphant GE Nybakken M Engle Q Xu CA Nelson S Sukupolvi-Petty, et al. J Virol 2006 80 24 12149 59
10. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. WD Crill JT Roehrig, J Virol 2001 75 16 7769 73
11. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. JT Roehrig RA Bolin RG Kelly, Virology 1998 246 2 317 28
12. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. S Sukupolvi-Petty SK Austin WE Purtha T Oliphant GE Nybakken JJ Schlesinger, et al. J Virol 2007 81 23 12816 26
13. Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus. GD Gromowski ND Barrett AD Barrett, J Virol 2008 82 17 8828 37
14. Neutralization and antibody-dependent enhancement of dengue viruses. SB Halstead, Adv Virus Res 2003 60 421 67
15. Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies. SH Xiang N Doka RK Choudhary J Sodroski JE Robinson, AIDS Res Hum Retroviruses 2002 18 16 1207 17
16. A novel enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to HIV-1 envelope glycoproteins based on immobilization of viral glycoproteins in microtiter wells coated with concanavalin A. JE Robinson D Holton J Liu H McMurdo A Murciano R Gohd, J Immunol Methods 1990 132 1 63 71
17. Identification of conserved and variant epitopes of human immunodeficiency virus type 1 (HIV-1) gp120 by human monoclonal antibodies produced by EBV-transformed cell lines. JE Robinson D Holton S Pacheco-Morell J Liu H McMurdo, AIDS Res Hum Retroviruses 1990 6 5 567 79
18. Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. EA Henchal JM McCown DS Burke MC Seguin WE Brandt, Am J Trop Med Hyg 1985 34 1 162 9
19. Inventor U.S. patent 6,165,477. JEN Ivy D Clements, 2000
20. Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay. AJ Cuzzubbo TP Endy A Nisalak S Kalayanarooj DW Vaughn SA Ogata, et al. Clin Diagn Lab Immunol 2001 8 6 1150 5
21. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain. KS Cole M Alvarez DH Elliott H Lam E Martin T Chau, et al. Virology 2001 290 1 59 73
22. Production and characterization of SIV envelope-specific rhesus monoclonal antibodies from a macaque asymptomatically infected with a live SIV vaccine. JE Robinson KS Cole DH Elliott H Lam AM Amedee R Means, et al. AIDS Res Hum Retroviruses 1998 14 14 1253 62
23. Rapid identification of dengue virus serotypes by using polymerase chain reaction. K Morita M Tanaka A Igarashi, J Clin Microbiol 1991 29 10 2107 10
24. Myanmar dengue outbreak associated with displacement of serotypes 2, 3, and 4 by dengue 1. HM Thu K Lowry TT Myint TN Shwe AM Han KK Khin, et al. Emerg Infect Dis 2004 10 4 593 7
25. Dengue 4 virus monoclonal antibodies identify epitopes that mediate immune infection enhancement of dengue 2 viruses. DM Morens CN Venkateshan SB Halstead, J Gen Virol 1987 68 Pt 1 91 8
26. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. SC Kliks A Nisalak WE Brandt L Wahl DS Burke, Am J Trop Med Hyg 1989 40 4 444 51 2712199
27. Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. DM Morens SB Halstead, J Gen Virol 1990 71 Pt 12 2909 14
28. Identification of a second class of IgG Fc receptors on human neutrophils. A 40 kilodalton molecule also found on eosinophils. RJ Looney DH Ryan K Takahashi HB Fleit HJ Cohen GN Abraham, et al. J Exp Med 1986 163 4 826 36
29. Enhancement of the Infectivity of Arboviruses by Specific Antisera Produced in Domestic Fowls. RA Hawkes, Aust J Exp Biol Med Sci 1964 42 465 82
30. Similarity and divergence in the development and expression of the mouse and human antibody repertoires. HW Schroeder Jr, Dev Comp Immunol 2006 30 1-2 119 35
31. Preferred CDRH3 lengths for antibodies with defined specificities. G Johnson TT Wu, Int Immunol 1998 10 12 1801 5
32. Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen. AV Collis AP Brouwer AC Martin, J Mol Biol 2003 325 2 337 54
33. Genomic organization of the mammalian MHC. A Kumanovics T Takada KF Lindahl, Annu Rev Immunol 2003 21 629 57
34. Sequence convergence in the peptide-binding region of primate and rodent MHC class Ib molecules. M Yeager S Kumar AL Hughes, Mol Biol Evol 1997 14 10 1035 41